The RxView Blog

Real world data, analytics, and insights for healthcare decision makers

Advera Health Analytics, Inc.

Using FAERS Data and Clinical Evidence to Compare HER2+ Antagonists

Posted by Andrea Demakas on Feb 9, 2017 7:30:00 AM

Recently, Advera Health released a comparative safety report of the HER2+ Antagonists. In this drug review, we analyzed FDA Adverse Event Reporting System (FAERS) and clinical trial data to better understand how the drugs in this class stacked up.

Read More

Topics: FAERS, Clinical Trials, Clinical Evidence, Breast Cancer

Real-Time Drug Safety Analysis with Evidex Alerts

Posted by Bob Kyle on Jan 20, 2017 10:30:00 AM

This week we launched Evidex Alerts, a new feature that provides our clients with real-time updates on the latest impactful drug safety news. This is a project that our development and analyst teams have worked on diligently for the last three months, and I am excited to announce that it became a reality this week. 

Read More

Topics: Drug Safety, Clinical Trials, Evidex

HHS Says they are Finally Going to Enforce Clinical Trial Reporting. Will Anything Really Change?

Posted by Brian Overstreet on Sep 22, 2016 10:30:00 AM

Last December, Stat News wrote a scathing report on the chronic under reporting of clinical trial results.  We followed that up in July with our own blog post, highlighting specific under reporting rates we’ve found in just a handful of indications.

Read More

Topics: Clinical Trials, Clinical Evidence

A Quest for Evidence

Posted by Brian Overstreet on Feb 12, 2016 10:33:44 AM

This week marks the sixth anniversary of the date that Bob Kyle, Henry Duong, and I incorporated Advera Health Analytics.  We started this journey with a mission to improve patient outcomes by making drug safety data more accessible and actionable.  We spent the early years developing our technologies, building our data delivery platform, and subjecting our early methodologies to peer review.  Two years ago we began to commercialize our enterprise data product and since then we’ve grown exponentially.

Read More

Topics: Clinical Trials, Hepatitis C, Clinical Evidence, Real World Evidence, Evidence

Mad as Hell and Not Going to Take This Anymore

Posted by Brian Overstreet on Dec 18, 2015 10:30:00 AM

We were blown away this week by Stat News’ investigation into the blatant underreporting of clinical trials data to the federally mandated website.  If you haven’t already read this masterful piece of journalism, please do so. No, really.  Go ahead and read it.  I’ll wait.

Read More

Topics: FDA, Clinical Trials

3 Ways Drug Safety is Like Car Sales in the 1980’s

Posted by Jim Davis on May 30, 2014 11:30:00 AM

What do I have to do, to get you into Lipitor today?

Studies have shown it’s the safest statin around!

Post-approval safety? Oh yeah, it’s great!!! Trust me!!! Our studies were fantastic!

You want to see data?

Well, I don't have the data, but I can tell you that everyone who has ever bought Lipitor from me, has LOVED it!

Before I get a lot of nasty emails, let me start by saying that although the reader could infer that I am, I ensure you that I AM NOT comparing pharma sales reps to used car salesmen. What I am doing is comparing the pharmaceutical industry, specifically drug safety, to the used car industry before the widespread proliferation of the World Wide Web.

Read More

Topics: Drug Safety, Managed Care Organization, Clinical Trials, pharmaceutical industry

Subscribe to Email Updates